These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

458 related articles for article (PubMed ID: 27066484)

  • 41. Carbonic anhydrase IX: regulation and role in cancer.
    Benej M; Pastorekova S; Pastorek J
    Subcell Biochem; 2014; 75():199-219. PubMed ID: 24146381
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The impact of tumour pH on cancer progression: strategies for clinical intervention.
    Ward C; Meehan J; Gray ME; Murray AF; Argyle DJ; Kunkler IH; Langdon SP
    Explor Target Antitumor Ther; 2020; 1(2):71-100. PubMed ID: 36046070
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Influence of hypoxia-dependent factors on the progression of neuroblastoma.
    Ameis HM; Drenckhan A; Freytag M; Izbicki JR; Supuran CT; Reinshagen K; Holland-Cunz S; Gros SJ
    Pediatr Surg Int; 2016 Feb; 32(2):187-92. PubMed ID: 26510737
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Expression of hypoxia-related tissue factors in astrocytic gliomas. A multivariate survival study with emphasis upon carbonic anhydrase IX.
    Korkolopoulou P; Perdiki M; Thymara I; Boviatsis E; Agrogiannis G; Kotsiakis X; Angelidakis D; Rologis D; Diamantopoulou K; Thomas-Tsagli E; Kaklamanis L; Gatter K; Patsouris E
    Hum Pathol; 2007 Apr; 38(4):629-38. PubMed ID: 17367605
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The interactome of metabolic enzyme carbonic anhydrase IX reveals novel roles in tumor cell migration and invadopodia/MMP14-mediated invasion.
    Swayampakula M; McDonald PC; Vallejo M; Coyaud E; Chafe SC; Westerback A; Venkateswaran G; Shankar J; Gao G; Laurent EMN; Lou Y; Bennewith KL; Supuran CT; Nabi IR; Raught B; Dedhar S
    Oncogene; 2017 Nov; 36(45):6244-6261. PubMed ID: 28692057
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pyruvate dehydrogenase kinase 1 and carbonic anhydrase IX targeting in hypoxic tumors.
    Kery M; Oravcova N; Radenkovic S; Iuliano F; Tomaskova J; Golias T
    Neoplasma; 2018 Dec; 66(1):63-72. PubMed ID: 30509100
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hypoxia-related carbonic anhydrase IX expression is associated with unfavourable response to first-line therapy in classical Hodgkin's lymphoma.
    Méhes G; Matolay O; Beke L; Czenke M; Jóna Á; Miltényi Z; Illés Á; Bedekovics J
    Histopathology; 2019 Apr; 74(5):699-708. PubMed ID: 30636023
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Advances in Anti-Cancer Drug Development Targeting Carbonic Anhydrase IX and XII.
    Mboge MY; McKenna R; Frost SC
    Top Anticancer Res; 2015; 5():3-42. PubMed ID: 30272043
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Phosphorylation of carbonic anhydrase IX controls its ability to mediate extracellular acidification in hypoxic tumors.
    Ditte P; Dequiedt F; Svastova E; Hulikova A; Ohradanova-Repic A; Zatovicova M; Csaderova L; Kopacek J; Supuran CT; Pastorekova S; Pastorek J
    Cancer Res; 2011 Dec; 71(24):7558-67. PubMed ID: 22037869
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cancer-associated carbonic anhydrases and their inhibition.
    Pastorekova S; Zatovicova M; Pastorek J
    Curr Pharm Des; 2008; 14(7):685-98. PubMed ID: 18336315
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The proteoglycan-like domain of carbonic anhydrase IX mediates non-catalytic facilitation of lactate transport in cancer cells.
    Ames S; Pastorekova S; Becker HM
    Oncotarget; 2018 Jun; 9(46):27940-27957. PubMed ID: 29963253
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Taking advantage of tumor cell adaptations to hypoxia for developing new tumor markers and treatment strategies.
    Ebbesen P; Pettersen EO; Gorr TA; Jobst G; Williams K; Kieninger J; Wenger RH; Pastorekova S; Dubois L; Lambin P; Wouters BG; Van Den Beucken T; Supuran CT; Poellinger L; Ratcliffe P; Kanopka A; Görlach A; Gasmann M; Harris AL; Maxwell P; Scozzafava A
    J Enzyme Inhib Med Chem; 2009 Apr; 24 Suppl 1():1-39. PubMed ID: 19330638
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Modulation of carbonic anhydrase 9 (CA9) in human brain cancer.
    Said HM; Supuran CT; Hageman C; Staab A; Polat B; Katzer A; Scozzafava A; Anacker J; Flentje M; Vordermark D
    Curr Pharm Des; 2010; 16(29):3288-99. PubMed ID: 20819065
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Sabotaging Role of Myeloid Cells in Anti-Angiogenic Therapy: Coordination of Angiogenesis and Immune Suppression by Hypoxia.
    Li C; Liu T; Bazhin AV; Yang Y
    J Cell Physiol; 2017 Sep; 232(9):2312-2322. PubMed ID: 27935039
    [TBL] [Abstract][Full Text] [Related]  

  • 55. HIF-1α promoted vasculogenic mimicry formation in hepatocellular carcinoma through LOXL2 up-regulation in hypoxic tumor microenvironment.
    Wang M; Zhao X; Zhu D; Liu T; Liang X; Liu F; Zhang Y; Dong X; Sun B
    J Exp Clin Cancer Res; 2017 Apr; 36(1):60. PubMed ID: 28449718
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CAIX Regulates Invadopodia Formation through Both a pH-Dependent Mechanism and Interplay with Actin Regulatory Proteins.
    Debreova M; Csaderova L; Burikova M; Lukacikova L; Kajanova I; Sedlakova O; Kery M; Kopacek J; Zatovicova M; Bizik J; Pastorekova S; Svastova E
    Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31167468
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The role of vascular endothelial growth factor in the hypoxic and immunosuppressive tumor microenvironment: perspectives for therapeutic implications.
    Tamura R; Tanaka T; Akasaki Y; Murayama Y; Yoshida K; Sasaki H
    Med Oncol; 2019 Nov; 37(1):2. PubMed ID: 31713115
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hypoxia, metabolism, and growth factor signaling in head and neck squamous cell carcinoma: correlation between primary and xenograft tumors.
    Stegeman H; Rademakers SE; Span PN; Takes RP; van der Kogel AJ; Kaanders JH; Bussink J
    Head Neck; 2014 Sep; 36(9):1288-95. PubMed ID: 24668936
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Molecular machineries of pH dysregulation in tumor microenvironment: potential targets for cancer therapy.
    Asgharzadeh MR; Barar J; Pourseif MM; Eskandani M; Jafari Niya M; Mashayekhi MR; Omidi Y
    Bioimpacts; 2017; 7(2):115-133. PubMed ID: 28752076
    [No Abstract]   [Full Text] [Related]  

  • 60. Sustain, Adapt, and Overcome-Hypoxia Associated Changes in the Progression of Lymphatic Neoplasia.
    Matolay O; Méhes G
    Front Oncol; 2019; 9():1277. PubMed ID: 31824854
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.